Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 7, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-12-24
DOI
10.1093/ofid/ofz532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MntC-Dependent Manganese Transport Is Essential for Staphylococcus aureus Oxidative Stress Resistance and Virulence
- (2018) Luke D. Handke et al. mSphere
- The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery
- (2018) A. Gurtman et al. Human Vaccines & Immunotherapeutics
- Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
- (2017) C. Buddy Creech et al. VACCINE
- Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
- (2017) Robert W. Frenck et al. VACCINE
- Epidemiology of Surgical Site Infection in a Community Hospital Network
- (2016) Arthur W. Baker et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study
- (2016) Helen Marshall et al. JOURNAL OF INFECTION
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Resolution Mapping of Bactericidal Monoclonal Antibody Binding Epitopes on Staphylococcus aureus Antigen MntC
- (2016) Alexey V. Gribenko et al. PLoS Pathogens
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
- (2015) Hector S Izurieta et al. LANCET INFECTIOUS DISEASES
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults
- (2015) Michael Nissen et al. VACCINE
- Adverse Clinical Outcomes and Resource Utilization Associated with Methicillin-Resistant and Methicillin-SensitiveStaphylococcus aureusInfections after Elective Surgery
- (2015) Rebecca S. Campbell et al. Surgical Infections
- Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial
- (2015) Jack Levy et al. Human Vaccines & Immunotherapeutics
- Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease
- (2015) Wouter Rozemeijer et al. PLoS One
- Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine
- (2014) Ingrid L. Scully et al. Frontiers in Immunology
- Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative Stress
- (2013) Luke D. Handke et al. PLoS One
- Capsular polysaccharides are an important immune evasion mechanism forStaphylococcus aureus
- (2013) Jasdeep S. Nanra et al. Human Vaccines & Immunotherapeutics
- A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure
- (2012) Julio Hawkins et al. Clinical and Vaccine Immunology
- Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis
- (2012) Annaliesa S. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- Development of a multicomponentStaphylococcus aureusvaccine designed to counter multiple bacterial virulence factors
- (2012) Annaliesa S. Anderson et al. Human Vaccines & Immunotherapeutics
- Staphylococcal Surgical Site Infections
- (2009) Deverick J. Anderson et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Surgical site infections: epidemiology, microbiology and prevention
- (2008) C.D. Owens et al. JOURNAL OF HOSPITAL INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search